Clinical Research

Thumbnail

Bilingual people have more efficient brains, imaging study shows

Researchers examined the brains of bilingual and monolingual people using fMRI, only to find improved communication between isolated regions in those who learn a second language at a young age.

Ron Blankstein, MD, Brigham and Womens Hospital, explains a study using AI opportunistic screening in non-cardiac CT scans looking for coronary artery disease.

Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

How patient positioning during blood pressure measurements impacts accuracy

Something as simple as resting a patient's arm the wrong way can make their BP reading inaccurate. 

artificial intelligence healthcare industry digest

ChatGPT is overly worried about ED patients

The popular AI chatbot tends to over-order X-rays, prescribe too many antibiotics and admit too many patients to the hospital when compared with a resident emergency department physician. 

Thumbnail

Vaping with e-cigarettes linked to multiple cardiovascular risks

This study adds to growing evidence that e-cigarettes play a significant role in cardiovascular problems, similar to smoking. Researchers hope their work can help lead to new public health policies. 

Banner ASC in Sun City, Arizona.

Low doses of radiation still increase risk of leukemia, lymphoma and myeloma

A new study found cumulative radiation exposure of 16 mSv to red bone marrow can cause an increased rate of some hematological malignancies.

Thumbnail

Following heart failure guidelines could save 1.2 million lives per year

Millions of heart failure patients who qualify for standard medical therapies do not receive treatment due to poor health literacy, limited access to care and medication costs.

AURORA trial results for Flurpiridaz F-18 PET vs. SPECT discussed by principal investigator Jamshid Maddahi, MD.

'This could be a paradigm shift': How PET with newly approved flurpiridaz compares to SPECT

GE HealthCare's flurpiridaz, the PET radiotracer that recently received FDA approval, offers several key benefits over SPECT. Jamshid Maddahi, MD, discussed the details in an exclusive interview.